Yong Sung Shin

Title: Yong Sung Shin: Innovator in Lung Cancer Diagnostics

Introduction

Yong Sung Shin is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the area of lung cancer detection. His innovative approach utilizes complex biomarker groups to enhance diagnostic accuracy.

Latest Patents

Yong Sung Shin holds a patent for a method that employs information on a complex biomarker group to diagnose lung cancer in a subject. The patent, titled "Method for using information on complex biomarker group to diagnose lung cancer in a subject and diagnostic kit and computing system using the same," outlines a systematic approach to diagnosing lung cancer. The method involves a computing system that acquires a model based on expression level data from individual biomarkers, such as CEA, HE4, ApoA2, TTR, sVCAM-1, and RANTES. This model is then used to analyze biological specimens from subjects to determine the presence of lung cancer.

Career Highlights

Yong Sung Shin is associated with Bioinfra Life Science Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving diagnostic methods and patient outcomes in oncology.

Collaborations

Yong Sung Shin collaborates with notable colleagues, including Chul Woo Kim and Yong Dai Kim. Their combined expertise contributes to the innovative projects at Bioinfra Life Science Inc.

Conclusion

Yong Sung Shin's contributions to lung cancer diagnostics through his patented methods exemplify the impact of innovation in healthcare. His work not only enhances diagnostic capabilities but also holds the potential to improve patient care significantly.